Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Micera

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Journal of Clinical Medicine|July 2, 2021
Sex Hormones Related Ocular Dryness in Breast Cancer WomenAntonella Grasso, Antonio Di Zazzo, Giuseppe Giannaccare, et al.
Biomolecules|September 27, 2025
Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD TrialRosanna Squitti, Alberto Benussi, Silvia Fostinelli, et al.
Genes|March 28, 2025
Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer PatientsConcetta Cafiero, Raffaele Palmirotta, Canio Martinelli, et al.
Acta Neuropathologica Communications|March 22, 2021
Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer's DiseaseValentina Latina, Giacomo Giacovazzo, Federica Cordella, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Journal of Clinical Medicine|July 2, 2021
Sex Hormones Related Ocular Dryness in Breast Cancer WomenAntonella Grasso, Antonio Di Zazzo, Giuseppe Giannaccare, et al.
Biomolecules|September 27, 2025
Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD TrialRosanna Squitti, Alberto Benussi, Silvia Fostinelli, et al.
Genes|March 28, 2025
Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer PatientsConcetta Cafiero, Raffaele Palmirotta, Canio Martinelli, et al.
Acta Neuropathologica Communications|March 22, 2021
Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer's DiseaseValentina Latina, Giacomo Giacovazzo, Federica Cordella, et al.
Pageof 15